Available Structures

8 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Engineered scFv 10LH bound to PHOX2B/HLA-A24:02 Heteromer
F6IR24; P61769; Q99453;
25-300
100GOL;NO3;
Complex structure of HLA2402 with recognizing SARS-CoV-2 epitope pep4 Heteromer
P0DTC2; P61769;
25-299
100
HLA-A24 in complex with modified 9mer WT1 peptide Heteromer
P19544; P61769;
25-298
100NAG;GOL;
Complex structure of HLA2402 with recognizing SARS-CoV-2 epitope QYIKWPWYI Heteromer
F6IR24; P0DTC2; P61769;
26-299
100
The complex between H25-11 TCR and HLA-A24 bound to HIV-1 Nef138-8 peptide Heteromer
F6IQZ4; P04601; P61769;
25-298
100
The complex between public TCR TD08 and HLA-A24 bound to HIV-1 Nef138-8 (2F) peptide Heteromer
F6IQZ4; P04601; P61769;
25-298
100
The complex between public TCR TD08 and HLA-A24 bound to HIV-1 Nef138-8 peptide Heteromer
F6IQZ4; P04601; P61769;
26-298
100
Single chain trimer HLA-A*24:02 (Y108C, A163C) with 8mer peptide YPPVPETF Heteromer
F6IR24; P16213; Q6NSI4;
25-296
99.25